Overview
Shengwang Wu practices practicing medicine in Chongqing, China.
Their clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease.
They are actively involved in clinical research, co-authoring 17 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shengwang Wu
Is Shengwang Wu a top-rated expert for Nonalcoholic Steatohepatitis (NASH)?
MediFind is an objective health platform that identifies experts based on real-world data. Shengwang Wu is classified as an Experienced expert for Nonalcoholic Steatohepatitis (NASH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shengwang Wu participate in research or clinical trials?
Yes. Shengwang Wu has published 17 articles and abstracts on conditions like Nonalcoholic Steatohepatitis (NASH). You can view a list of Shengwang Wu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Non-Alcoholic Fatty Liver Disease
- Nonalcoholic Steatohepatitis (NASH)